Japanese pump and pumping equipment manufacturer Nikkiso has acquired an additional stake in Weigao Blood Purification, a subsidiary of Chinese medical products conglomerate Shandong Weigao Group Medical Polymer.
It has increased its stake to 5% for Rmb100 million (US$15.1 million) and now controls the board. It will change from the existing three-member board (nominated as to two directors by the company and as to one director by Xia Lie Bo) to a five-member board.
Shandong Weigao’s stake in the group is now diluted to 46.9%.